FdaApplication
NDA 216352
Identifiers
- fda_app_no: NDA216352
Properties
| Property | Value |
|---|---|
| applicant_name | LUYE INNOMIND PHARMA (SHIJIAZHUANG) CO LTD |
| application_type | NDA |
| approval_date | 2024-07-26 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERZOFRI | PALIPERIDONE PALMITATE | 117MG/0.75ML (117MG/0.75ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ERZOFRI | PALIPERIDONE PALMITATE | 234MG/1.5ML (156MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ERZOFRI | PALIPERIDONE PALMITATE | 39MG/0.25ML (39MG/0.25ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ERZOFRI | PALIPERIDONE PALMITATE | 351MG/2.25ML (156MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ERZOFRI | PALIPERIDONE PALMITATE | 156MG/ML (156MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ERZOFRI | PALIPERIDONE PALMITATE | 78MG/0.5ML (78MG/0.5ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
6 products